Global Elastomeric Infusion Pumps Market By Type (Continuous Rate Elastomeric Pumps, Variable Rate Elastomeric Pumps), By Application (Hospitals, Clinics, Ambulatory Surgical Centres, Home Care, Others), By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2022–2031

Market.us announces the publication of its most recently generated research report titled, “Global Elastomeric Infusion Pumps Market by Product Type (Continuous Rate Elastomeric Pumps & Variable Rate Elastomeric Pumps), By Treatment Type (Pain Management, Antibiotic/Antiviral, Chemotherapy & Others), By End User Type ( Hospitals, Ambulatory Surgical Centers & Clinics, & Home Care Settings) and by Region – Global Forecast to 2029,” which offers a holistic view of the global elastomeric infusion pumps market through systematic segmentation that covers every aspect of the target market.

The global elastomeric infusion pumps market is projected to be US$ 558.6 Mn in 2019 to reach US$ 1,144.0 Mn by 2029 at a CAGR of 7.5%.

Elastomeric infusion pumps are disposable drug delivery pumps that deliver fluids like an antibiotic, anesthetics, and analgesics into the patient body. It is also known as balloon pumps and non-electronic medication pumps, primarily used in the medical field for the administration of various liquid drugs. The essential pressure for administrating the drug derives from the elastomeric layer existing inside the pump. However, pump failure can have significant implications on patient safety that making it compulsory for pumps to be functioned by a trained person.

The elastomeric infusion pumps market has gained significant popularity over the years. Moreover, prompt growth in industrialization, especially in emerging economies in the Asia Pacific, East African belt, and Eastern Europe regions, is helping the production and R&D of low-cost medical devices. Furthermore, a rise in the adoption of elastomeric pumps is attributed to boosting growth in demand for disposable ambulatory pumps, and increasing preference for home healthcare. Also, the rising rate of hospitalization and number of surgeries are likely to promote the growth of the global elastomeric infusion pump market. Additionally, the availability of well-developed manufacturing infrastructure, low-cost labor, and trained specialists in countries such as China are also among the key factors driving the growth of the market. Manufacturers of elastomeric infusion pumps, like Baxter and B. Braun Melsungen AG, have manufacturing divisions as well as R&D centers based in emerging economies such as India, and Brazil. Besides, continuous innovations and advancements in medical devices and increasing awareness about elastomeric infusion pumps for the administration of various disease applications, along with government initiatives & funding for the R&D of elastomeric infusion pumps, are also influencing positively the growth of the elastomeric infusion pumps during the forecast period.

Global Elastomeric Infusion Pumps Market Revenue (US$ Mn), 2019–2029 

Elastomeric infusion pumps offer various benefits and advantages as compared to conventional electronic pumps. Some include portability, feasibility, and reduced scope for human error. Also, ease of usage, discreteness, and fewer chances of fatal errors is expected to fuel the demand for the target market. The increasing number of clinical trials and FDA approvals for elastomeric drug delivery pumps in the recent past, owing to the increasing demand for novel therapeutic drugs and medical devices, coupled with rising investments in R&D activities in the pharmaceutical industry is expected to create new space for the target market.

The lack of developed medical infrastructure in developing and under-developed countries in the Asia Pacific and the Middle East & Africa is expected to hamper the growth of the global elastomeric infusion pumps market.

Global elastomeric infusion pumps market is segmented on the basis of product type, treatment type, end-user type, and region. Based on product type, the market is segmented into continuous rate elastomeric pumps & variable rate elastomeric pumps. The continuous rate elastomeric pumps segment accounts for the majority share and is expected to register the highest growth over the forecast period. Based on treatment type, the market is segmented into pain management, antibiotic/antiviral, chemotherapy, and others. The Pain Management segment accounts for a majority share in the global elastomeric infusion pumps market, followed by the chemotherapy segment.

Global Elastomeric Infusion Pumps Market Share by Treatment Type, 2019

Based on end-user, the market is segmented into Hospitals, Ambulatory Surgical Centers & Clinics, & Home Care Settings. The Hospitals segment accounts for a majority share in the global Elastomeric Infusion Pumps market, followed by Ambulatory Surgical Centers & Clinics segment.

Based on region, the market is segmented into North America, Europe, APAC, South America, and Middle East Africa. North America accounts for the majority share in the global Elastomeric Infusion Pumps market, followed by Europe.

The research report on the global elastomeric infusion pumps market includes profiles of some of the major companies such as Terumo Corporation, Nipro Corp., Baxter International Inc., B. Braun Melsungen AG, Avanos Medical, Inc., Woo Young Medical Co., Ltd., pfm medical ag, Gamastech Srl, Ambu A/S, Fresenius SE & Co. KGaA, LEVENTON S.A.U., etc.

Key Market Segments

Type

• Continuous Rate Elastomeric Pumps
• Variable Rate Elastomeric Pumps

Application

• Hospitals
• Clinics
• Ambulatory Surgical Centres
• Home Care
• Others

Key Market Players included in the report:

• Terumo Corporation
• Nipro Corp.
• Baxter International Inc.
• B. Braun Melsungen AG
• Avanos Medical Inc.
• Woo Young Medical Co.Ltd.
• pfm medical ag
• Gamastech Srl
• Ambu A/S
• Fresenius SE & Co. KGaA
• LEVENTON S.A.U.

For the Global Elastomeric Infusion Pumps Market research study, the following years have been considered to estimate the market size: